·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 24, 2025

In the news: Measles outbreak update, states take action on prior authorization, telemedcine prescribing rule delayed, murine typhus may make a comeback and more.

Publications & Newsletters

Your powerful ally

The AMA helps physicians build a better future for medicine, advocating in the courts and on the Hill to remove obstacles to patient care and confront today’s greatest health crises.

·
1 Min Read

Pearl of the Week: Rethink prescription renewals

Find resources on developing a system for annual prescription renewals. 

series
Public Health
AMA STEPS Forward® Pearl of the Week
·
9 Min Read

March 21, 2025: National Advocacy Update

Reminder: March 31 Medicare MIPS reporting deadline and more in the latest National Advocacy Update.

Advocacy Update
Physician or health care professional reviewing patient lab results on a computer desktop
UPDATED
·
3 Min Read

Addressing and managing drug shortages

The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.

Public Health
·
5 Min Read

Feb. 7, 2025: National Advocacy Update

Physicians to CMS: Connect MIPS Value Pathways to patient care and more in the latest National Advocacy Update.

Advocacy Update
·
3 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 27, 2025

In the news: SARS-CoV-2 reinfection linked to long COVID risk, threat of human bird flu pandemic grows, FDA approves new nonopioid pain medication and more.

Publications & Newsletters
·
7 Min Read

Jan. 24, 2025: National Advocacy Update

New rules issued for telemedicine prescribing and more in the latest National Advocacy Update.

Advocacy Update
·
8 Min Read

Jan. 10, 2025: National Advocacy Update

OCR issues new proposed regulation with updates to the HIPAA Security Rule and more in the latest National Advocacy Update.

Advocacy Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 23, 2024

In the news: Tirzepatide approved for sleep apnea, mutations seen in bird flu virus, Systane eye drops recalled and more.

Publications & Newsletters